Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Extension of Dutasteride in BPH
NCT00969072Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dutasteride in benign prostatic hyperplasia (BPH), sponsored by GSK. Started Aug 2003; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00969072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00969072.